AstraZeneca’s rare disease drug falls short in late-stage trial

15 hours ago 1

An experimental AstraZeneca (NASDAQ:AZN) drug, anselamimab, failed to extend survival or cut heart-related hospitalizations in patients with a rare plasma cell disorder, disappointing hopes it could benefit those with the most severe cases.

The company said Wednesday the drug showed

Recommended For You

More Trending News

Read Entire Article
  1. Homepage
  2. Finance
  3. AstraZeneca’s rare disease drug falls short in late-stage trial

Related

Kinder Morgan positioned to continue growing from natural gas demand, executives say

Kinder Morgan positioned to continue growing from natural ga...

1 hour ago 0
South Plains outlines low to mid-single-digit loan growth outlook while expanding Dallas lending team

South Plains outlines low to mid-single-digit loan growth ou...

1 hour ago 0
Oil prices slide as U.S. gasoline inventories surge in middle of summer driving season

Oil prices slide as U.S. gasoline inventories surge in middl...

2 hours ago 0
AAR targets 9% organic sales growth and margin improvement in fiscal 2026 as new business wins drive outlook

AAR targets 9% organic sales growth and margin improvement i...

2 hours ago 0
Michigan fails in bid to build semiconductor manufacturing plant, Whitmer blames ‘massive economic uncertainty’

Michigan fails in bid to build semiconductor manufacturing p...

2 hours ago 0
Coke tight-lipped on Trump’s promise to make American Coke with real sugar again

Coke tight-lipped on Trump’s promise to make American Coke w...

2 hours ago 0
Kinder Morgan outlines $9.3B project backlog growth and expects significant LNG-driven demand through 2030

Kinder Morgan outlines $9.3B project backlog growth and expe...

2 hours ago 0
Kinder Morgan in charts: Adjusted EBITDA from natural gas pipelines dips in Q2

Kinder Morgan in charts: Adjusted EBITDA from natural gas pi...

3 hours ago 0
Air India probe finds 'no issues' with Boeing 787 fuel control switches - report

Air India probe finds 'no issues' with Boeing 787 fuel contr...

3 hours ago 0
Great Southern Bancorp GAAP EPS of $1.72 beats by $0.38, revenue of $59.17M beats by $3.15M

Great Southern Bancorp GAAP EPS of $1.72 beats by $0.38, rev...

3 hours ago 0
Trump brokers deal for Coca-Cola to use ‘REAL Cane Sugar’ in U.S. Coke products

Trump brokers deal for Coca-Cola to use ‘REAL Cane Sugar’ in...

3 hours ago 0
NKGen Biotech announces new funding to regain compliance with reporting obligations and listing standards

NKGen Biotech announces new funding to regain compliance wit...

3 hours ago 0
Northisle announces C$30 million financing

Northisle announces C$30 million financing

3 hours ago 0
Pyrophyte Acquisition Corp. II announces pricing of $175 million initial public offering

Pyrophyte Acquisition Corp. II announces pricing of $175 mil...

3 hours ago 0
OpenAI adds Google to its list of cloud infrastructure providers

OpenAI adds Google to its list of cloud infrastructure provi...

3 hours ago 0
Biofrontera files to sell 13.6M shares of common stock by selling shareholders

Biofrontera files to sell 13.6M shares of common stock by se...

3 hours ago 0
F.N.B. Q2 2025 Earnings Preview

F.N.B. Q2 2025 Earnings Preview

4 hours ago 0
WisdomTree Q2 2025 Earnings Preview

WisdomTree Q2 2025 Earnings Preview

4 hours ago 0
Synovus Q2 profit beats as credit loss provision shrinks; lifts revenue guide

Synovus Q2 profit beats as credit loss provision shrinks; li...

4 hours ago 0
Home BancShares Non-GAAP EPS of $0.58 beats by $0.01, revenue of $273.6M beats by $10.99M

Home BancShares Non-GAAP EPS of $0.58 beats by $0.01, revenu...

4 hours ago 0

Trending

1. oscar ustari
2. today's news headlines
3. minnesota vs lafc
4. வானிலை
5. dear lottery sambad
6. today's national news
7. india post
8. వాతావరణం
9. gerardo valenzuela
10. neymar

Popular

بانک مرکزی: بابک زنجانی مجوز فعالیت اقتصادی ندارد

بانک مرکزی: بابک زنجانی مجوز فعالیت اقتصادی ندارد

6 days ago 4
پنج مصدوم براثر تصادف پراید با دیوار در گنبدکاووس

پنج مصدوم براثر تصادف پراید با دیوار در گنبدکاووس

6 days ago 4
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved